全文获取类型
收费全文 | 10910篇 |
免费 | 1038篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 124篇 |
儿科学 | 464篇 |
妇产科学 | 214篇 |
基础医学 | 1385篇 |
口腔科学 | 234篇 |
临床医学 | 1218篇 |
内科学 | 2012篇 |
皮肤病学 | 483篇 |
神经病学 | 1062篇 |
特种医学 | 333篇 |
外科学 | 1450篇 |
综合类 | 202篇 |
一般理论 | 10篇 |
预防医学 | 947篇 |
眼科学 | 77篇 |
药学 | 724篇 |
中国医学 | 10篇 |
肿瘤学 | 1027篇 |
出版年
2023年 | 103篇 |
2022年 | 127篇 |
2021年 | 221篇 |
2020年 | 169篇 |
2019年 | 238篇 |
2018年 | 262篇 |
2017年 | 212篇 |
2016年 | 245篇 |
2015年 | 252篇 |
2014年 | 293篇 |
2013年 | 439篇 |
2012年 | 582篇 |
2011年 | 574篇 |
2010年 | 322篇 |
2009年 | 310篇 |
2008年 | 551篇 |
2007年 | 531篇 |
2006年 | 495篇 |
2005年 | 485篇 |
2004年 | 448篇 |
2003年 | 436篇 |
2002年 | 381篇 |
2001年 | 231篇 |
2000年 | 241篇 |
1999年 | 243篇 |
1998年 | 115篇 |
1997年 | 108篇 |
1996年 | 95篇 |
1995年 | 96篇 |
1994年 | 87篇 |
1992年 | 162篇 |
1991年 | 201篇 |
1990年 | 183篇 |
1989年 | 151篇 |
1988年 | 187篇 |
1987年 | 164篇 |
1986年 | 145篇 |
1985年 | 178篇 |
1984年 | 123篇 |
1983年 | 124篇 |
1982年 | 77篇 |
1979年 | 118篇 |
1978年 | 111篇 |
1977年 | 73篇 |
1976年 | 76篇 |
1975年 | 72篇 |
1974年 | 95篇 |
1973年 | 110篇 |
1972年 | 77篇 |
1971年 | 76篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Hassen Lena M. Albarrak Rana A. Albahlal Reem A. Alsaqabi Dimah K. Hassen Ikhlass M. Daghestani Maha H. Alqurtas Eman M. Alkhalaf Abdulaziz T. Bedaiwi Mohammed K. Omair Mohammed A. Almaghlouth Ibrahim A. 《Quality of life research》2022,31(11):3229-3239
Quality of Life Research - The COVID-19 pandemic might add to the stressors experienced by people living with rheumatic diseases. This study aimed to examine rheumatic patients’ functional... 相似文献
2.
3.
ABSTRACTA monocausal bacteriological understanding of infectious disease orients tuberculosis control efforts towards antimicrobial interventions. A bias towards technological solutions can leave multistranded public health and social interventions largely neglected. In the context of globalising biomedical approaches to infectious disease control, this ethnography-inspired review article reflects upon the implementation of rapid diagnostic technology in low- and middle-income countries. Fieldwork observations in Vietnam provided a stimulus for a critical review of the global rollout of tuberculosis diagnostic technology. To address local needs in tuberculosis control, health managers in resource-poor settings are readily cooperating with international donors to deploy novel diagnostic technologies throughout national tuberculosis programme facilities. Increasing investment in new diagnostic technologies is predicated on the supposition that these interventions will ameliorate disease outcomes. However, suboptimal treatment control persists even when accurate diagnostic technologies are available, suggesting that promotion of singular technological solutions can distract from addressing systemic change, without which disease susceptibility, propagation of infection, detection gaps, diagnostic delays, and treatment shortfalls persist. 相似文献
4.
5.
6.
J.L. Bernat A.M. D'Alessandro F.K. Port T.P. Bleck S.O. Heard J. Medina S.H. Rosenbaum M.A. DeVita R.S. Gaston R.M. Merion M.L. Barr W.H. Marks H. Nathan K. O'Connor D.L. Rudow A.B. Leichtman P. Schwab N.L. Ascher R.A. Metzger V. Mc Bride W. Graham D. Wagner J. Warren F.L. Delmonico 《American journal of transplantation》2006,6(2):281-291
A national conference on organ donation after cardiac death (DCD) was convened to expand the practice of DCD in the continuum of quality end-of-life care. This national conference affirmed the ethical propriety of DCD as not violating the dead donor rule. Further, by new developments not previously reported, the conference resolved controversy regarding the period of circulatory cessation that determines death and allows administration of pre-recovery pharmacologic agents, it established conditions of DCD eligibility, it presented current data regarding the successful transplantation of organs from DCD, it proposed a new framework of data reporting regarding ischemic events, it made specific recommendations to agencies and organizations to remove barriers to DCD, it brought guidance regarding organ allocation and the process of informed consent and it set an action plan to address media issues. When a consensual decision is made to withdraw life support by the attending physician and patient or by the attending physician and a family member or surrogate (particularly in an intensive care unit), a routine opportunity for DCD should be available to honor the deceased donor's wishes in every donor service area (DSA) of the United States. 相似文献
7.
Lena Adamson 《The American journal of occupational therapy》2003,57(5):578-581
The purpose of the present study was to examine the self-image of a group of young persons with cerebral palsy. The respondents (3 girls and 4 boys, ages 12 to 17 years) were interviewed and asked to complete a personality inventory. The results from the personality inventory revealed that the respondents viewed themselves in a very positive manner and rated markedly higher than norm groups. This positive view corresponded well with the findings of the interview. The following conclusions are made: Further studies on self-image and the psychosocial development of adolescents with disabilities should (a) focus on the social interaction outside their immediate families, and (b) continue to use and develop methods where these adolescents can give voice to their own experiences and opinions. 相似文献
8.
Use of fMRI to predict psychiatric adverse effects of interferon treatment for Hepatitis C – preliminary report
下载免费PDF全文
![点击此处可从《Neuropsychiatric Disease and Treatment》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Donald H Marks Mehdi Adineh Binquan Wang Sudeepa Gupta 《Neuropsychiatric Disease and Treatment》2007,3(5):655-667
Interferon alfa2 (IFN-α2) is a parenterally administered cytokine used to treat patients with Hepatitis C and B, and malignancy. Interferon (INF) has a relatively high rate of central nervous system (CNS) adverse effects, including agitation, depression, fatigue, cognitive dysfunction, suicidal thought and drug craving. Using functional magnetic resonance imaging (fMRI) we studied patients with Hepatitis C virus (HCV) infection who were not more than mildly clinically depressed at baseline for their CNS reaction to IFN-α2. During fMRI, patients underwent visual stimulation with pictures designed to induce feelings of depression. In the two patients who became clinically depressed or markedly anxious while on treatment with interferon, but not in patients who did not experience these effects, there was a significant activation in specific areas of the brain known to be involved with depression, along with an increase above baseline in the Beck Depression Scale for the patient who developed INF-induced depression. The activation pattern differed from that previously observed for endogenous depression, indicating that INF-induced depression may differ in its underlying neuropathology. Functional magnetic resonance imaging can be an important tool in understanding and monitoring for (INF and other) medication-induced CNS effects, and response to treatment. 相似文献
9.
Ludger Grote MD PhD Lena Leissner MD Jan Hedner MD PhD Jan Ulfberg MD PhD 《Movement disorders》2009,24(10):1445-1452
Iron deficiency may exacerbate symptoms in the Restless Legs Syndrome (RLS). We investigated the effect of intravenous iron sucrose or placebo on symptoms in patients with RLS and mild to moderate iron deficit. Sixty patients with primary RLS (seven males, age 46 (9) years, S‐ferritin ≤45 μg/L) recruited from a cohort of 231 patients were randomly assigned in a 12‐months double‐blind, multi‐centre study of iron sucrose 1000 mg (n = 29) or saline (n = 31). The primary efficacy variable was the RLS severity scale (IRLS) score at week 11. Median IRLS score decreased from 24 to 7 (week 11) after iron sucrose and from 26 to 17 after placebo (P = 0.123, N.S. for between treatment comparison). The corresponding scores at week 7 were 12 and 20 in the two groups (P = 0.017). Drop out rate because of lack of efficacy at 12 months was 19/31 after placebo and 5/29 patients after iron sucrose (Kaplan–Meier estimate, log rank test P = 0.0006) suggesting an iron induced superior long term RLS symptom control. Iron sucrose was well tolerated. This study showed a lack of superiority of iron sucrose at 11 weeks but found evidence that iron sucrose reduced RLS symptoms both in the acute phase (7 weeks) and during long‐term follow up in patients with variable degree of iron deficiency. Further studies on target patient groups, dosing and dosing intervals are warranted before iron sucrose could be considered for treatment of iron deficient patients with RLS. © 2009 Movement Disorder Society 相似文献
10.